Haloperidol for treatment of cannabinoid hyperemesis syndrome

被引：55

作者：

Hickey, Jami L. ^{[1
]}

Witsil, Joanne C. ^{[1
]}

Mycyk, Mark B. ^{[1
]}

机构：

[1] Cook Cty Hosp, Dept Emergency Med, Chicago, IL 60612 USA

来源：

AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2013年 / 31卷 / 06期

关键词：

D O I：

10.1016/j.ajem.2013.02.021

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Cannabinoid hyperemesis syndrome (CHS) is a condition characterized by cyclical vomiting without other identifiable cause in patients with chronic cannabis use. Patients with CHS report that compulsive bathing and hot showers are the only reliable treatments to improve symptoms. Cannabinoid hyperemesis syndrome is usually unresponsive to conventional pharmacologic antiemetics, and patients often require hospital admission. We report a case of CHS that improved significantly after treatment with haloperidol in the emergency department.

引用

页码：1003.e5 / 1003.e6

页数：2

共 9 条

[1] Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
Allen, JH
de Moore, GM
Heddle, R
Twartz, JC
[J]. GUT, 2004, 53 (11) : 1566 - 1570
[2] Cannabinoid Hyperemesis Relieved by Compulsive Bathing
Chang, Yoon Hee
Windish, Donna M.
[J]. MAYO CLINIC PROCEEDINGS, 2009, 84 (01) : 76 - 78
[3] Analysis of Tolerance and Behavioral/Physical Dependence during Chronic CB1 Agonist Treatment: Effects of CB1 Agonists, Antagonists, and Noncannabinoid Drugs
Desai, Rajeev I.
Thakur, Ganesh A.
Vemuri, V. Kiran
Bajaj, Shama
Makriyannis, Alexandros
Bergman, Jack
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (02) : 319 - 328
[4] Consensus guidelines for managing postoperative nausea and vomiting
Gan, TJ
Meyer, T
Apfel, CC
Chung, F
Davis, PJ
Eubanks, S
Kovac, A
Philip, BK
Sessler, DI
Temo, J
Tramèr, MR
Watcha, M
[J]. ANESTHESIA AND ANALGESIA, 2003, 97 (01) : 62 - 71
[5] Juurlink DN, 2011, GOLDFRANKS TOXICOLOG, P1003
[6] Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation
Patterson, Dale A.
Smith, EmmaLeigh
Monahan, Mark
Medvecz, Andrew
Hagerty, Beth
Krijger, Lisa
Chauhan, Aakash
Walsh, Mark
[J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2010, 23 (06) : 790 - 793
[7] Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys
Schulze, David R.
Carroll, F. Ivy
McMahon, Lance R.
[J]. PSYCHOPHARMACOLOGY, 2012, 222 (03) : 425 - 438
[8] Cannabinoid Hyperemesis: A Case Series of 98 Patients
Simonetta, Douglas A.
Oxentenko, Amy S.
Herman, Margot L.
Szostek, Jason H.
[J]. MAYO CLINIC PROCEEDINGS, 2012, 87 (02) : 114 - 119
[9] Cannabinoid Hyperemesis Syndrome: Literature Review and Proposed Diagnosis and Treatment Algorithm
Wallace, Erik A.
Andrews, Sarah E.
Garmany, Chad L.
Jelley, Martina J.
[J]. SOUTHERN MEDICAL JOURNAL, 2011, 104 (09) : 659 - 664

← 1 →